Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-26 @ 3:21 AM
Study NCT ID:
NCT01555268
Status:
COMPLETED
Last Update Posted:
2022-09-13
First Post:
2012-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10-31
Start Date Type:
ACTUAL
Primary Completion Date:
2013-09-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-16
First Submit QC Date:
None
Study First Post Date:
2012-03-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-08
Last Update Post Date:
2022-09-13
Last Update Post Date Type:
ACTUAL